NEW YORK, April 25, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced the expansion of the National Health and Wellness Survey (NHWS) into Russia. NHWS is the largest global database of self-reported patient insights in the healthcare industry.
“Russia has a rapidly changing healthcare environment, where the unmet needs of patients remain high, so it’s an attractive growth opportunity for pharma companies,” says Gina Isherwood, Regional Brand Director with Kantar Health. “Russia is also quite different from established countries in Western Europe and other emerging markets. By collecting data directly from Russian patients, NHWS helps companies gain an understanding of the Russian patient and the Russian healthcare market and how they differ from patients worldwide.”
Survey responses were collected directly from Russian patients and represent the adult urban population. Topics covered include health status, attitudes, behaviors and outcomes among other unique information specific to Russia’s healthcare market.
The NHWS provides broad coverage of healthcare, with results projected to the population to deliver prevalence information in more than 165 conditions. NHWS includes information for patients who are diagnosed, undiagnosed yet symptomatic, untreated and for patients treated with prescription and/or over-the-counter medications
Kantar Health conducts NHWS annually in the US, Europe, Asia and Latin America. NHWS provides disease-specific measures that help healthcare clients:
- Size market opportunities using specific patient profiles
- Quantify unmet needs for early development, marketing and reimbursement strategies
- Measure direct and indirect costs
- Gain insight into disease-specific segments
- Develop publication strategies directed at specific consumer or patient segments
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With offices in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.